{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T23:24:55Z","timestamp":1787181895383,"version":"build-2736575974"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007161","name":"Instituto Polit\u00e9cnico Nacional Secretar\u00eda de Investigaci\u00f3n y Posgrado","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007161","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.biopha.2026.119806","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T13:54:36Z","timestamp":1786024476000},"page":"119806","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Antitrypanosomatid and antiamitochondriate activity of new cyclohexyl-quinoxaline-7-carboxylate-1,4-di-N-oxide derivatives: An in silico and in vitro approach toward the elucidation of their mechanisms of action"],"prefix":"10.1016","volume":"202","author":[{"given":"Alonzo","family":"Gonz\u00e1lez-Gonz\u00e1lez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilian","family":"Y\u00e9pez-Mulia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Moreno-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Chan-Bacab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Citlali","family":"V\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rusely","family":"Encalada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Saavedra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eyra","family":"Ortiz-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alma D.","family":"Paz-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruy","family":"P\u00e9rez-Montfort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nallely","family":"Cabrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itzhel","family":"Garc\u00eda-Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Enr\u00edquez-Flores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoalli","family":"Mart\u00ednez-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"L\u00f3pez-Vel\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9842-4167","authenticated-orcid":false,"given":"Gildardo","family":"Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2026.119806_bib1","unstructured":"World Health Organization. Neglected tropical diseases. 2024 [Available from: https:\/\/www.who.int\/health-topics\/neglected-tropical-diseases#tab=tab_1] Accessed: March 20, 2024."},{"issue":"4","key":"10.1016\/j.biopha.2026.119806_bib2","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/cbdd.13921","article-title":"Current status of quinoxaline and quinoxaline 1,4-di-N-oxides derivatives as potential antiparasitic agents","volume":"98","author":"Soto-S\u00e1nchez","year":"2021","journal-title":"Chem. Biol. Drug. Des."},{"issue":"4","key":"10.1016\/j.biopha.2026.119806_bib3","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/em.21839","article-title":"Unveiling Benznidazole's mechanism of action through overexpression of DNA repair proteins in Trypanosoma cruzi","volume":"55","author":"Raj\u00e3o","year":"2014","journal-title":"Environ. Mol. Mutagen."},{"key":"10.1016\/j.biopha.2026.119806_bib4","first-page":"343","article-title":"Quello che non si cerca difficilmente si trova: la malattia di Chagas","volume":"17","author":"Briceno","year":"2016","journal-title":"G. Ital. Cardiol."},{"issue":"3","key":"10.1016\/j.biopha.2026.119806_bib5","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/ced.14919","article-title":"Treatment options for leishmaniasis","volume":"47","author":"Pradhan","year":"2022","journal-title":"Clin. Exp. Dermatol."},{"issue":"12","key":"10.1016\/j.biopha.2026.119806_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006052","article-title":"Drug resistance and treatment failure in leishmaniasis: a 21st century challenge","volume":"11","author":"Ponte-Sucre","year":"2017","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"5","key":"10.1016\/j.biopha.2026.119806_bib7","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/QCO.0000000000000668","article-title":"Giardiasis treatment: an update with a focus on refractory disease","volume":"33","author":"M\u00f8rch","year":"2020","journal-title":"Curr. Opin. Infect. Dis."},{"issue":"1","key":"10.1016\/j.biopha.2026.119806_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijmm.2019.151358","article-title":"Intestinal amoebiasis: 160 years of its first detection and still remains as a health problem in developing countries","volume":"310","author":"Carrero","year":"2020","journal-title":"Int. J. Med. Microbiol."},{"issue":"3","key":"10.1016\/j.biopha.2026.119806_bib9","first-page":"953","article-title":"Esters of quinoxaline 1,4-di-N-oxide with cytotoxic activity on tumor cell lines based on NCI-60 Panel","volume":"16","author":"Rivera","year":"2017","journal-title":"Iran. J. Pharm. Res. IJPR"},{"issue":"5","key":"10.1016\/j.biopha.2026.119806_bib10","doi-asserted-by":"crossref","first-page":"682","DOI":"10.2174\/1871520616666160630175927","article-title":"Ester of quinoxaline-7-carboxylate 1,4-di-N-oxide as apoptosis inductors in K-562 Cell Line: an in vitro, QSAR and DFT Study","volume":"17","author":"Rivera","year":"2017","journal-title":"Anti-Cancer Agents Med. Chem."},{"issue":"5","key":"10.1016\/j.biopha.2026.119806_bib11","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/ardp.201500468","article-title":"Quinoxaline-based scaffolds targeting tyrosine kinases and their potential anticancer activity","volume":"349","author":"El Newahie","year":"2016","journal-title":"Arch. der Pharm."},{"issue":"5","key":"10.1016\/j.biopha.2026.119806_bib12","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.201700325","article-title":"Quinoxaline and quinoxaline-1,4-di-N-oxides: an emerging class of antimycobacterials","volume":"351","author":"Keri","year":"2018","journal-title":"Arch. der Pharm."},{"issue":"6","key":"10.1016\/j.biopha.2026.119806_bib13","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.3390\/molecules23061453","article-title":"Anti-mycobacterium tuberculosis activity of esters of quinoxaline 1,4-Di-N-oxide","volume":"23","author":"Palos","year":"2018","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.biopha.2026.119806_bib14","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.ijantimicag.2017.04.016","article-title":"In vitro and in vivo assessment of newer quinoxaline\u2013oxadiazole hybrids as antimicrobial and antiprotozoal agents","volume":"50","author":"Patel","year":"2017","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.biopha.2026.119806_bib15","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.bioorg.2017.12.017","article-title":"Design, synthesis, antibacterial evaluation and molecular docking studies of some new quinoxaline derivatives targeting dihyropteroate synthase enzyme","volume":"76","author":"El-Attar","year":"2018","journal-title":"Bioorg. Chem."},{"issue":"4","key":"10.1016\/j.biopha.2026.119806_bib16","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.exppara.2011.01.009","article-title":"Trypanocidal properties, structure\u2013activity relationship and computational studies of quinoxaline 1,4-di-N-oxide derivatives","volume":"127","author":"Estevez","year":"2011","journal-title":"Exp. Parasitol."},{"issue":"15","key":"10.1016\/j.biopha.2026.119806_bib17","doi-asserted-by":"crossref","first-page":"4550","DOI":"10.1016\/j.bmc.2013.05.036","article-title":"Synthesis and in vitro evaluation of new ethyl and methyl quinoxaline-7-carboxylate 1,4-di-N-oxide against Entamoeba histolytica","volume":"21","author":"Duque-Monta\u00f1o","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.biopha.2026.119806_bib18","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.ejmech.2013.04.065","article-title":"Novel quinoxaline 1,4-di-N-oxide derivatives as new potential antichagasic agents","volume":"66","author":"Torres","year":"2013","journal-title":"Eur. J. Med. Chem."},{"issue":"6","key":"10.1016\/j.biopha.2026.119806_bib19","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1007\/s00436-014-3850-8","article-title":"Anti-Trypanosoma cruzi and anti-leishmanial activity by quinoxaline-7-carboxylate 1,4-di-N-oxide derivatives","volume":"113","author":"Villalobos-Rocha","year":"2014","journal-title":"Parasitol. Res."},{"issue":"3","key":"10.1016\/j.biopha.2026.119806_bib20","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.bmcl.2015.12.070","article-title":"Synthesis and biological evaluation of quinoxaline di-N-oxide derivatives with in vitro trypanocidal activity","volume":"26","author":"P\u00e9rez-Silanes","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"2","key":"10.1016\/j.biopha.2026.119806_bib21","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3390\/molecules22020220","article-title":"Trypanocidal activity of quinoxaline 1,4 Di-N-oxide derivatives as trypanothione reductase inhibitors","volume":"22","author":"Chac\u00f3n-Vargas","year":"2017","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.biopha.2026.119806_bib22","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00436-017-5635-3","article-title":"Isopropyl quinoxaline-7-carboxylate 1,4-di-N-oxide derivatives induce regulated necrosis-like cell death on Leishmania (Leishmania) mexicana","volume":"117","author":"Chac\u00f3n-Vargas","year":"2018","journal-title":"Parasitol. Res."},{"issue":"4","key":"10.1016\/j.biopha.2026.119806_bib23","doi-asserted-by":"crossref","first-page":"428","DOI":"10.2174\/1570180816666190618115854","article-title":"In vitro and in vivo evaluation of quinoxaline 1,4-di-N-oxide against Giardia lamblia","volume":"17","author":"Barbosa-Cabrera","year":"2020","journal-title":"Lett. Drug. Des. & Discov."},{"issue":"21","key":"10.1016\/j.biopha.2026.119806_bib24","doi-asserted-by":"crossref","first-page":"13315","DOI":"10.3390\/ijms232113315","article-title":"In vitro and in silico analysis of new n-butyl and isobutyl quinoxaline-7-carboxylate 1,4-di-N-oxide derivatives against Trypanosoma cruzi as trypanothione reductase inhibitors","volume":"23","author":"Gonz\u00e1lez-Gonz\u00e1lez","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"14","key":"10.1016\/j.biopha.2026.119806_bib25","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1016\/j.bmcl.2004.04.088","article-title":"Quinoxaline N, N \u2032-dioxide derivatives and related compounds as growth inhibitors of Trypanosoma cruzi. Structure\u2013activity relationships","volume":"14","author":"Aguirre","year":"2004","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"1","key":"10.1016\/j.biopha.2026.119806_bib26","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2174\/1389557521666210126142541","article-title":"Quinoxaline 1,4-di-N-oxide derivatives: are they unselective or selective inhibitors?","volume":"22","author":"Rivera","year":"2022","journal-title":"Mini-Rev. Med. Chem."},{"issue":"6","key":"10.1016\/j.biopha.2026.119806_bib27","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s00894-023-05579-4","article-title":"Molecular docking and dynamic simulations of quinoxaline 1,4-di-N-oxide as inhibitors for targets from Trypanosoma cruzi, Trichomonas vaginalis, and Fasciola hepatica","volume":"29","author":"Gonz\u00e1lez-Gonz\u00e1lez","year":"2023","journal-title":"J. Mol. Model."},{"issue":"2","key":"10.1016\/j.biopha.2026.119806_bib28","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s00436-019-06580-8","article-title":"Biological activity of esters of quinoxaline-7-carboxylate 1,4-di-N-oxide against E. histolytica and their analysis as potential thioredoxin reductase inhibitors","volume":"119","author":"Soto-S\u00e1nchez","year":"2020","journal-title":"Parasitol. Res."},{"issue":"0014-2999 (Print)","key":"10.1016\/j.biopha.2026.119806_bib29","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.ejphar.2007.12.006","article-title":"Q39, a novel synthetic quinoxaline 1,4-Di-N-oxide compound with anti-cancer activity in hypoxia","volume":"10","author":"Weng","year":"2008","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119806_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0085706","article-title":"A Quinoxaline derivative as a potent chemotherapeutic agent, alone or in combination with benznidazole, against Trypanosoma cruzi","volume":"9","author":"Rodrigues","year":"2014","journal-title":"PLoS. ONE"},{"key":"10.1016\/j.biopha.2026.119806_bib31","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ejmech.2014.11.018","article-title":"Synthesis and biological evaluation of novel 2, 3-disubstituted quinoxaline derivatives as antileishmanial and antitrypanosomal agents","volume":"90","author":"Cogo","year":"2015","journal-title":"Eur. J. Med. Chem."},{"issue":"6","key":"10.1016\/j.biopha.2026.119806_bib32","doi-asserted-by":"crossref","first-page":"3433","DOI":"10.1128\/AAC.02582-15","article-title":"In vitro and in vivo activities of 2,3-diarylsubstituted quinoxaline derivatives against Leishmania amazonensis","volume":"60","author":"Kaplum","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"issue":"4","key":"10.1016\/j.biopha.2026.119806_bib33","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3390\/ph17040487","article-title":"Dual antitubercular and antileishmanial profiles of quinoxaline Di-N-oxides containing an amino acidic side chain","volume":"17","author":"Gonz\u00e1lez","year":"2024","journal-title":"Pharmaceuticals"},{"issue":"12","key":"10.1016\/j.biopha.2026.119806_bib34","doi-asserted-by":"crossref","first-page":"7303","DOI":"10.1128\/AAC.03834-14","article-title":"Discovery of novel antigiardiasis drug candidates","volume":"58","author":"Kulakova","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"issue":"4","key":"10.1016\/j.biopha.2026.119806_bib35","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.bmcl.2005.11.025","article-title":"Synthesis and antiprotozoal activity of some new synthetic substituted quinoxalines","volume":"16","author":"Hui","year":"2006","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"2","key":"10.1016\/j.biopha.2026.119806_bib36","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ejmech.2003.11.008","article-title":"Synthesis, anti-mycobacterial, anti-trichomonas and anti-candida in vitro activities of 2-substituted-6,7-difluoro-3-methylquinoxaline 1,4-dioxides","volume":"39","author":"Carta","year":"2004","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.biopha.2026.119806_bib37","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3389\/fphar.2016.00064","article-title":"Quinoxaline 1,4-di-N-oxides: biological activities and mechanisms of actions","volume":"7","author":"Cheng","year":"2016","journal-title":"Front. Pharmacol."},{"issue":"3","key":"10.1016\/j.biopha.2026.119806_bib38","doi-asserted-by":"crossref","first-page":"485","DOI":"10.2478\/acph-2021-0032","article-title":"Esters of quinoxaline-7-carboxylate-1,4-di-N-oxide as Trichomonas vaginalis triosephosphate isomerase inhibitors","volume":"71","author":"Palos","year":"2021","journal-title":"Acta Pharm."},{"issue":"1","key":"10.1016\/j.biopha.2026.119806_bib39","doi-asserted-by":"crossref","DOI":"10.1080\/14756366.2024.2413018","article-title":"Expanding the antiprotozoal activity and the mechanism of action of n-butyl and iso-butyl ester of quinoxaline-1,4-di- N -oxide derivatives against Giardia lamblia, Trichomonas vaginalis, and Entamoeba histolytica. An in vitro and in silico approach","volume":"39","author":"Gonz\u00e1lez-Gonz\u00e1lez","year":"2024","journal-title":"J. Enzym. Inhib. Med. Chem."},{"issue":"7","key":"10.1016\/j.biopha.2026.119806_bib40","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1590\/S0100-40422011000700008","article-title":"Synthesis of quinoxaline 1,4-di-n-oxide derivatives on solid support using room temperature and microwave-assisted solvent-free procedures","volume":"34","author":"G\u00f3mez-Caro","year":"2011","journal-title":"Quim. Nova"},{"issue":"3","key":"10.1016\/j.biopha.2026.119806_bib41","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1550-7408.2002.tb00523.x","article-title":"In vitro effect of nitazoxanide against Entamoeba histolytica, Giardia intestinalis and Trichomonas vaginalis Trophozoites","volume":"49","author":"Cedillo-Rivera","year":"2002","journal-title":"J. Eukaryot. Microbiol."},{"key":"10.1016\/j.biopha.2026.119806_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101231","article-title":"Gamma-glutamylcysteine synthetase and tryparedoxin 1 exert high control on the antioxidant system in Trypanosoma cruzi contributing to drug resistance and infectivity","volume":"26","author":"Gonz\u00e1lez-Ch\u00e1vez","year":"2019","journal-title":"Redox Biol."},{"issue":"2","key":"10.1016\/j.biopha.2026.119806_bib43","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.bbagen.2014.10.029","article-title":"Metabolic control analysis of the Trypanosoma cruzi peroxide detoxification pathway identifies tryparedoxin as a suitable drug target","volume":"1850","author":"Gonz\u00e1lez-Ch\u00e1vez","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.biopha.2026.119806_bib44","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/1074-5521(95)90091-8","article-title":"Using evolutionary changes to achieve species-specific inhibition of enzyme action--studies with triosephosphate isomerase","volume":"12","author":"G\u00f3mez-Puyou","year":"1995","journal-title":"Chem. Biol."},{"issue":"10","key":"10.1016\/j.biopha.2026.119806_bib45","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.1007\/s00436-020-06868-0","article-title":"Rabeprazole inhibits several functions of Entamoeba histolytica related with its virulence","volume":"119","author":"Mart\u00ednez-P\u00e9rez","year":"2020","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.biopha.2026.119806_bib46","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1758-2946-3-33","article-title":"Open Babel: An open chemical toolbox","volume":"3","author":"O'Boyle","year":"2011","journal-title":"J. Cheminform."},{"issue":"1","key":"10.1016\/j.biopha.2026.119806_bib47","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0969-2126(99)80011-2","article-title":"Crystal structure of Trypanosoma cruzi trypanothione reductase in complex with trypanothione, and the structure-based discovery of new natural product inhibitors","volume":"7","author":"Bond","year":"1999","journal-title":"Structure"},{"issue":"8","key":"10.1016\/j.biopha.2026.119806_bib48","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1021\/jm900185q","article-title":"Molecular basis of antimony treatment in Leishmaniasis","volume":"52","author":"Baiocco","year":"2009","journal-title":"J. Med. Chem."},{"issue":"18","key":"10.1016\/j.biopha.2026.119806_bib49","doi-asserted-by":"crossref","first-page":"10062","DOI":"10.1073\/pnas.96.18.10062","article-title":"Crystal structure of triosephosphate isomerase from Trypanosoma cruzi in hexane","volume":"96","author":"Gao","year":"1999","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.biopha.2026.119806_bib50","doi-asserted-by":"crossref","unstructured":"S. Lara-Gonzalez, H. Salgado-Lugo, L.G. Brieba, Crystal structure of Trichomonas vaginalis triosephosphate isomerase TVAG_096350 gene (Val-45 variant), Protein Data Bank, (2012). https:\/\/doi.org\/10.2210\/pdb3qst\/pdb.","DOI":"10.2210\/pdb3qst\/pdb"},{"issue":"2","key":"10.1016\/j.biopha.2026.119806_bib51","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jsb.2016.02.015","article-title":"X-ray structures of thioredoxin and thioredoxin reductase from Entamoeba histolytica and prevailing hypothesis of the mechanism of Auranofin action","volume":"194","author":"Parsonage","year":"2016","journal-title":"J. Struct. Biol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119806_bib52","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13321-021-00522-2","article-title":"GNINA 1.0: molecular docking with deep learning","volume":"13","author":"McNutt","year":"2021","journal-title":"J. Cheminform."},{"key":"10.1016\/j.biopha.2026.119806_bib53","unstructured":"Schr\u00f6dinger, LLC, The PyMOL Molecular Graphics System, Version 3.1.3, (2024). https:\/\/pymol.org."},{"key":"10.1016\/j.biopha.2026.119806_bib54","doi-asserted-by":"crossref","first-page":"W270","DOI":"10.1093\/nar\/gkr366","article-title":"SwissDock, a protein-small molecule docking web service based on EADock DSS","volume":"39","author":"Grosdidier","year":"2011","journal-title":"Nucleic Acids Res."},{"issue":"W1","key":"10.1016\/j.biopha.2026.119806_bib55","doi-asserted-by":"crossref","first-page":"W324","DOI":"10.1093\/nar\/gkae300","article-title":"SwissDock 2024: major enhancements for small-molecule docking with Attracting Cavities and AutoDock Vina","volume":"52","author":"Bugnon","year":"2024","journal-title":"Nucleic Acids Res."},{"issue":"W1","key":"10.1016\/j.biopha.2026.119806_bib56","doi-asserted-by":"crossref","first-page":"W530","DOI":"10.1093\/nar\/gkab294","article-title":"PLIP 2021: expanding the scope of the protein\u2013ligand interaction profiler to DNA and RNA","volume":"49","author":"Adasme","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.biopha.2026.119806_bib57","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","article-title":"GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers","volume":"1-2","author":"Abraham","year":"2015","journal-title":"SoftwareX"},{"issue":"23","key":"10.1016\/j.biopha.2026.119806_bib58","doi-asserted-by":"crossref","first-page":"5834","DOI":"10.3390\/ijms20235834","article-title":"Virtual screening using pharmacophore models retrieved from molecular dynamic simulations","volume":"20","author":"Polishchuk","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2026.119806_bib59","doi-asserted-by":"crossref","first-page":"42717","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"issue":"W1","key":"10.1016\/j.biopha.2026.119806_bib60","doi-asserted-by":"crossref","first-page":"W513","DOI":"10.1093\/nar\/gkae303","article-title":"ProTox 3.0: a webserver for the prediction of toxicity of chemicals","volume":"52","author":"Banerjee","year":"2024","journal-title":"Nucleic Acids Res."},{"issue":"W1","key":"10.1016\/j.biopha.2026.119806_bib61","doi-asserted-by":"crossref","first-page":"W422","DOI":"10.1093\/nar\/gkae236","article-title":"ADMETlab 3.0: an updated comprehensive online ADMET prediction platform enhanced with broader coverage, improved performance, API functionality and decision support","volume":"52","author":"Fu","year":"2024","journal-title":"Nucleic Acids Res."},{"issue":"12","key":"10.1016\/j.biopha.2026.119806_bib62","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1016\/j.bmcl.2011.04.072","article-title":"New 1,4-di-N-oxide-quinoxaline-2-ylmethylene isonicotinic acid hydrazide derivatives as anti-Mycobacterium tuberculosis agents","volume":"21","author":"Torres","year":"2011","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"3","key":"10.1016\/j.biopha.2026.119806_bib63","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1093\/jac\/dkz473","article-title":"Tolerance to nifurtimox and benznidazole in adult patients with chronic Chagas\u2019 disease","volume":"75","author":"Jackson","year":"2020","journal-title":"J. Antimicrob. Chemoth."},{"issue":"12","key":"10.1016\/j.biopha.2026.119806_bib64","doi-asserted-by":"crossref","first-page":"1344.e1","DOI":"10.1016\/j.cmi.2018.06.006","article-title":"Toxicity of nifurtimox as second-line treatment after benznidazole intolerance in patients with chronic Chagas disease: when available options fail","volume":"24","author":"Crespillo-And\u00fajar","year":"2018","journal-title":"Clin. Microbiol. Infec."},{"issue":"16","key":"10.1016\/j.biopha.2026.119806_bib65","doi-asserted-by":"crossref","first-page":"3148","DOI":"10.1021\/jm000156+","article-title":"Use of an additional hydrophobic binding site, the Z Site, in the rational drug design of a new class of stronger trypanothione reductase inhibitor, quaternary alkylammonium phenothiazines","volume":"43","author":"Khan","year":"2000","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.biopha.2026.119806_bib66","first-page":"68","article-title":"Avances en la identificaci\u00f3n de blancos terap\u00e9uticos y el dise\u00f1o racional de f\u00e1rmacos contra la enfermedad de chagas","volume":"30","author":"Garc\u00eda-Torres","year":"2011","journal-title":"Rev. Educ. Bioqu\u00edmica"},{"issue":"5","key":"10.1016\/j.biopha.2026.119806_bib67","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.jmb.2004.06.056","article-title":"Inactivation of triosephosphate isomerase from Trypanosoma cruzi by an agent that perturbs its dimer interface","volume":"341","author":"T\u00e9llez-Valencia","year":"2004","journal-title":"J. Mol. Biol."},{"issue":"4","key":"10.1016\/j.biopha.2026.119806_bib68","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1093\/protein\/gzh048","article-title":"Understanding protein lids: structural analysis of active hinge mutants in triosephosphate isomerase","volume":"17","author":"Kursula","year":"2004","journal-title":"Protein Eng. Des. Sel."},{"issue":"36","key":"10.1016\/j.biopha.2026.119806_bib69","doi-asserted-by":"crossref","first-page":"8482","DOI":"10.1021\/bi00151a014","article-title":"Segmental movement: definition of the structural requirements for loop closure in catalysis by triosephosphate isomerase","volume":"31","author":"Sampson","year":"1992","journal-title":"Biochemistry"},{"issue":"34","key":"10.1016\/j.biopha.2026.119806_bib70","doi-asserted-by":"crossref","first-page":"23254","DOI":"10.1074\/jbc.M802145200","article-title":"Structural basis of human triosephosphate isomerase deficiency","volume":"283","author":"Rodr\u00edguez-Almaz\u00e1n","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.biopha.2026.119806_bib71","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"23","author":"Lipinski","year":"1997","journal-title":"Adv. Drug. Deliv. Rev."},{"issue":"1","key":"10.1016\/j.biopha.2026.119806_bib72","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1021\/cc9800071","article-title":"A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases","volume":"1","author":"Ghose","year":"1999","journal-title":"J. Comb. Chem."},{"issue":"12","key":"10.1016\/j.biopha.2026.119806_bib73","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1021\/jm020017n","article-title":"Molecular properties that influence the oral bioavailability of drug candidates","volume":"45","author":"Veber","year":"2002","journal-title":"J. Med. Chem."},{"issue":"21","key":"10.1016\/j.biopha.2026.119806_bib74","doi-asserted-by":"crossref","first-page":"3867","DOI":"10.1021\/jm000292e","article-title":"Prediction of drug absorption using multivariate statistics","volume":"43","author":"Egan","year":"2000","journal-title":"J. Med. Chem."},{"issue":"12","key":"10.1016\/j.biopha.2026.119806_bib75","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1021\/jm015507e","article-title":"Simple selection criteria for drug-like chemical matter","volume":"44","author":"Muegge","year":"2001","journal-title":"J. Med. Chem."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226008425?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226008425?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T22:50:06Z","timestamp":1787179806000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332226008425"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":75,"alternative-id":["S0753332226008425"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119806","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antitrypanosomatid and antiamitochondriate activity of new cyclohexyl-quinoxaline-7-carboxylate-1,4-di-N-oxide derivatives: An in silico and in vitro approach toward the elucidation of their mechanisms of action","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119806","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119806"}}